Updates from The Motley Fool

Latest updates on ZIOPHARM Oncology from Fool.com.

Stock Performance

ZIOP vs. S&P 500 | 2 Year Performance
ZIOP 1-Day Stock Chart
ZIOP 5-Day Stock Chart
ZIOP 1-Month Stock Chart
ZIOP 3-Month Stock Chart
ZIOP 6-Month Stock Chart
ZIOP 1-Year Stock Chart
ZIOP 2-Year Stock Chart
ZIOP 5-Year Stock Chart
View Interactive ZIOP Charts
Sponsored by

Key Data Points

Primary metrics and data points about ZIOPHARM Oncology.
Current Price: $6.89
Prev Close: $7.29
Open: $7.28
Bid: $6.86
Ask: $6.87
Day's Range: $6.74 - $7.29
52wk Range: $4.56 - $14.93
Volume: 2,094,622
Avg Vol 2,053,482
Market Cap: $901.82M
P/E (ttm): -7.59
EPS (ttm): -$0.96
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about ZIOPHARM Oncology.
CAPS Rating 2 out of 5
120 Outperform
19 Underperform
CAPS All Stars
15 Outperform
10 Underperform

How do you think ZIOPHARM Oncology will perform against the market?

You pick for ZIOPHARM Oncology is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Jonathan J. Lewis, CEO

100% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for ZIOPHARM Oncology.

ZIOPHARM Oncology Inc. is a biopharmaceutical company engaged in the development and commercialization of small molecule and synthetic biology approaches to new cancer therapies.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers